“…The tolerance to these antibiotics is crucial due to the global tendency of utilizing Colistin in dealing with of MDR A. baumannii infections (Chen et al, 2015). Colistin resistance in A. baumannii has previously been reported in Spain (Khoshbakht et al, 2023) and Kingdom of Bahrain (Al-Rashed et al, 2023), and a study from China reported a lower resistance rate to minocycline and tigecycline (Zhu et al, 2022). However, in this study, two Colistin-resistant A. baumannii isolates were identified and considered pandrug resistant bacteria.…”